The exercise period for warrants series TO 13 ("TO 13") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") ended on 15 September 2025. The preliminary outcome indicates that a total ...
Since Alligator Bioscience is considered to conduct protection-worthy activities according to the Swedish Screening of Foreign Direct Investments Act (Sw. lag (2023:560) om granskning av utländska ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results